SEARCH

SEARCH BY CITATION

References

  • 1
    Vignola AM, Chanez P, Godard P, Bousquet J. Relationships between rhinitis and asthma. Allergy 1998;53: 833839.
  • 2
    Simons FE. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol 1999;104: 534540.
  • 3
    American Thoracic Society Workshop. Immunobiology of asthma and rhinitis. Pathogenic factors and therapeutic options. Am J Respir Crit Care Med 1999; 160: 17781787.
  • 4
    Vignola AM, Bousquet J. Rhinitis and asthma: a continuum of disease? Clin Exp Allergy 2001;31: 674677.
  • 5
    Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991;46: 895901.
  • 6
    Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 1994;94: 895901.
  • 7
    Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104: 301304.
  • 8
    Yawn BP, Yunginger JW, Wollan PC, Reed CE, Silverstein MD, Harris AG. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol 1999; 103: 5459.
  • 9
    Pariente P, Le-Pen C, Los F, Bousquet J. Quality-of-life outcomes and the use of antihistamines in a French national population-based sample of patients with perennial rhinitis. Pharmacoeconomics 1997;12: 585595.
  • 10
    Reicin A, White R, Weinstein SF, Finn AF Jr, Nguyen H, Peszek I, et al. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 2000;160: 24812488.
  • 11
    Lundback B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998;28(S.2):310.
  • 12
    Linneberg A, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T. Secular trends of allergic asthma in Danish adults. The Copenhagen Allergy Study. Respir Med 2001;95: 258264.
  • 13
    Celedon JC, Palmer LJ, Weiss ST, Wang B, Fang Z, Xu X. Asthma, rhinitis, and skin test reactivity to aeroallergens in families of asthmatic subjects in Anqing, China. Am J Respir Crit Care Med 2001;163: 11081112.
  • 14
    Townley R, Ryo U, Kolotin B, Kang B. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol 1975;56: 429437.
  • 15
    Leynaert B, Bousquet J, Henry C, Liard R, Neukirch F. Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med 1997;156: 14131420.
  • 16
    Sotomayor H, Badier M, Vervloet D, Orehek J. Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen. Reversal by corticosteroids. Am Rev Respir Dis 1984;130: 5658.
  • 17
    Boulet LP, Morin D, Milot J, Turcotte H. Bronchial responsiveness increases after seasonal antigen exposure in non-asthmatic subjects with pollen-induced rhinitis. Ann Allergy 1989;63: 114119.
  • 18
    Witteman AM, Sjamsoedin DH, Jansen HM, Van-der-Zee JS. Differences in nonspecific bronchial responsiveness between patients with asthma and patients with rhinitis are not explained by type and degree of inhalant allergy. Int Arch Allergy Immunol 1997;112: 6572.
  • 19
    Dahl R, Mygind N. Mechanisms of airflow limitation in the nose and lungs. Clin Exp Allergy 1998;2: 1725.
  • 20
    Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104: 513.
  • 21
    Pearce N, Douwes J, Beasley R. Is allergen exposure the major primary cause of asthma? Thorax 2000;55: 424431.
  • 22
    Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990;323: 502507.
  • 23
    Peat JK, Tovey E, Toelle BG, Haby MM, Gray EJ, Mahmic A, et al. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996;153: 141146.
  • 24
    Peat J, Tovey E, Mellis C, Leeder S, Woolcock A. Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 1973;23: 812820.
  • 25
    Neukirch C, Henry C, Leynaert B, Liard R, Bousquet J, Neukirch F. Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Allergy Clin Immunol 1999;103: 709711.
  • 26
    Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG, Gergen P, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 1997;336: 13561363.
  • 27
    Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J Allergy Clin Immunol 1992;90: 579588.
  • 28
    Charpin D, Hughes B, Mallea M, Sutra JP, Balansard G, Vervloet D. Seasonal allergic symptoms and their relation to pollen exposure in south-east France. Clin Exp Allergy 1993;23: 435439.
  • 29
    Sari-Minodier I, Charpin D, Signouret M, Poyen D, Vervloet D. Prevalence of self-reported respiratory symptoms in workers exposed to isocyanates. J Occup Environ Med 1999;41: 582588.
  • 30
    Malo JL, Lemiere C, Desjardins A, Cartier A. Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Eur Respir J 1997;10: 15131515.
  • 31
    Baur X. Baker's asthma: causes and prevention. Int Arch Occup Environ Health 1999;72: 292296.
  • 32
    Brisman J, Jarvholm B. Bakery work, atopy and the incidence of self-reported hay fever and rhinitis. Eur Respir J 1999;13: 502507.
  • 33
    Yach D, Myers J, Bradshaw D, Benatar SR. A respiratory epidemiologic survey of grain mill workers in Cape Town, South Africa. Am Rev Respir Dis 1985;131: 505510.
  • 34
    Wilhelmsson B, Jernudd Y, Ripe E, Holmberg K. Nasal hypersensitivity in wood furniture workers. An allergological and immunological investigation with special reference to mould and wood. Allergy 1984;39: 586595.
  • 35
    Kanerva L, Vaheri E. Occupational allergic rhinitis in Finland. Int Arch Occup Environ Health 1993;64: 565568.
  • 36
    Corrado OJ, Osman J, Davies RJ. Asthma and rhinitis after exposure to glutaraldehyde in endoscopy units. Hum Toxicol 1986;5: 325328.
  • 37
    Bardana EJ Jr, Andrach RH. Occupational asthma secondary to low molecular weight agents used in the plastic and resin industries. Eur J Respir Dis 1983;64: 241251.
  • 38
    Burge PS, Perks W, O'Brien IM, Hawkins R, Green M. Occupational asthma in an electronics factory. Thorax 1979;34: 1318.
  • 39
    Platts-Mills TA, Longbottom J, Edwards J, Heymann PW. Asthma and rhinitis related to laboratory rats: use of a purified rat urinary allergen to study exposure in laboratories and the human immune response. N Engl Reg Allergy Proc 1987;8: 245251.
  • 40
    Krakowiak A, Szulc B, Gorski P. Occupational respiratory diseases in laboratory animal workers: initial results. Int J Occup Med Environ Health 1997;10: 3136.
  • 41
    Seward JP. Medical surveillance of allergy in laboratory animal handlers. ILAR J 2001;42: 4754.
  • 42
    Kopferschmit-Kubler MC, Stenger R, Blaumeiser M, Eveilleau C, Bessot JC, Pauli G, et al. Asthma, rhinitis and urticaria following occupational exposure to cyanoacrylate glues. Rev Mal Respir 1996;13: 305307.
  • 43
    Kopp SK, McKay RT, Moller DR, Cassedy K, Brooks SM. Asthma and rhinitis due to ethylcyanoacrylate instant glue. Ann Int Med 1985;102: 613615.
  • 44
    Jaeger D, Kleinhans D, Czuppon AB, Baur X. Latex-specific proteins causing immediate-type cutaneous, nasal, bronchial, and systemic reactions. J Allergy Clin Immunol 1992;89: 759768.
  • 45
    Charous BL, Blanco C, Tarlo S, Hamilton RG, Baur X, Beezhold D, et al. Natural rubber latex allergy after 12 years: recommendations and perspectives. J Allergy Clin Immunol 2002;109: 3134.
  • 46
    Leino T, Tammilehto L, Hytonen M, Sala E, Paakkulainen H, Kanerva L. Occupational skin and respiratory diseases among hairdressers. Scand J Work Environ Health 1998;24: 398406.
  • 47
    Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995;333: 107112.
  • 48
    Malo JL, Lemiere C, Desjardins A, Cartier A. Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Eur Respir J 1997;10: 15131515.
  • 49
    Seward JP. Medical surveillance of allergy in laboratory animal handlers. ILAR J 2001;42: 4754.
  • 50
    Daroca P, Crespo JF, Reano M, James JM, Lopez-Rubio A, Rodriguez J. Asthma and rhinitis induced by exposure to raw green beans and chards. Ann Allergy Asthma Immunol 2000;85: 215218.
  • 51
    Gorski P, Krakowiak A, Ruta U. Nasal and bronchial responses to flour–inhalation in subjects with occupationally induced allergy affecting the airway. Int Arch Occup Environ Health 2000;73: 488497.
  • 52
    Heederik D, Houba R. An exploratory quantitative risk assessment for high molecular weight sensitizers: wheat flour. Ann Occup Hyg 2001;45: 175185.
  • 53
    Kujala V. A review of current literature on epidemiology of immediate glove irritation and latex allergy. Occup Med (Lond) 1999;49: 39.
  • 54
    Larese Filon F, Bosco A, Fiorito A, Negro C, Barbina P. Latex symptoms and sensitisation in health care workers. Int Arch Occup Environ Health 2001;74: 219223.
  • 55
    Piirila P, Estlander T, Hytonen M, Keskinen H, Tupasela O, Tuppurainen M. Rhinitis caused by ninhydrin develops into occupational asthma. Eur Respir J 1997;10: 19181921.
  • 56
    Piirila P, Estlander T, Keskinen H, Jolanki R, Laakkonen A, Pfaffli P, et al. Occupational asthma caused by triglycidyl isocyanurate (TGIC). Clin Exp Allergy 1997;27: 510514.
  • 57
    Moscato G, Galdi E, Scibilia J, Dellabianca A, Omodeo P, Vittadini G, et al. Occupational asthma, rhinitis and urticaria due to piperacillin sodium in a pharmaceutical worker. Eur Respir J 1995;8: 467469.
  • 58
    Quirce S, Baeza ML, Tornero P, Blasco A, Barranco R, Sastre J. Occupational asthma caused by exposure to cyanoacrylate. Allergy 2001;56: 446449.
  • 59
    Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000;161: 20512057.
  • 60
    Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107: 469476.
  • 61
    Chakir J, Laviolette M, Boutet M, Laliberte R, Dube J, Boulet LP. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 1996;75: 735744.
  • 62
    Djukanovic R, Lai CK, Wilson JW, Britten KM, Wilson SJ, Roche WR, et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992;5: 538544.
  • 63
    Chakir J, Laviolette M, Turcotte H, Boutet M, Boulet LP. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol 2000;106: 904910.
  • 64
    Calhoun WJ, Jarjour NN, Gleich GJ, Stevens CA, Busse WW. Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis 1993;147: 14651471.
  • 65
    Calhoun WJ, Reed HE, Moest DR, Stevens CA. Enhanced superoxide production by alveolar macrophages and air–space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1992;145: 317325.
  • 66
    Shaver JR, O'Connor JJ, Pollice M, Cho SK, Kane GC, Fish JE, et al. Pulmonary inflammation after segmental ragweed challenge in allergic asthmatic and nonasthmatic subjects. Am J Respir Crit Care Med 1995;152: 11891197.
  • 67
    Packe GE, Ayres JG. Asthma outbreak during a thunderstorm. Lancet 1985;2: 199204.
  • 68
    Venables KM, Allitt U, Collier CG, Emberlin J, Greig JB, Hardaker PJ, et al. Thunderstorm-related asthma – the epidemic of 24/25 June 1994. Clin Exp Allergy 1997;27: 725736.
  • 69
    Anto JM, Sunyer J. Thunderstorms: a risk factor for asthma attacks (editorial; comment). Thorax 1997;52: 669670.
  • 70
    Bauman A. Asthma associated with thunderstorms (editorial; comment). Br Med J 1996;312: 590591.
  • 71
    Celenza A, Fothergill J, Kupek E, Shaw RJ. Thunderstorm associated asthma: a detailed analysis of environmental factors. Br Med J 1996;312: 604607.
  • 72
    Knox RB. Grass pollen, thunderstorms and asthma. Clin Exp Allergy 1993;23: 354359.
  • 73
    Marks GB, Colquhoun JR, Girgis ST, Koski MH, Treloar AB, Hansen P, et al. Thunderstorm outflows preceding epidemics of asthma during spring and summer. Thorax 2001;56: 468471.
  • 74
    Suphioglu C, Singh MB, Taylor P, Bellomo R, Holmes P, Puy R, et al. Mechanism of grass-pollen-induced asthma. Lancet 1992;339: 569572.
  • 75
    Girgis ST, Marks GB, Downs SH, Kolbe A, Car GN, Paton R. Thunderstorm-associated asthma in an inland town in south-eastern Australia. Who is at risk? Eur Respir J 2000;16: 38.
  • 76
    Gern JE, Busse WW. The role of viral infections in the natural history of asthma. J Allergy Clin Immunol 2000;106: 201212.
  • 77
    Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996;154: 654660.
  • 78
    Lemanske R Jr, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989;83: 110.
  • 79
    Papadopoulos NG, Johnston SL. Viruses and asthma exacerbations. Thorax 1998;53: 913914.
  • 80
    Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ, et al. Rhinoviruses infect the lower airways. J Infect Dis 2000;181: 18751884.
  • 81
    Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997;155: 11591161.
  • 82
    Igarashi Y, Goldrich MS, Kaliner MA, Irani AM, Schwartz LB, White MV. Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects. J Allergy Clin Immunol 1995;95: 716725.
  • 83
    Jeffery P. Bronchial biopsies and airway inflammation. Eur Respir J 1996;9: 15831587.
  • 84
    Holmberg K, Bake B, Pipkorn U. Nasal mucosal blood flow after intranasal allergen challenge. J Allergy Clin Immunol 1988;81: 541547.
  • 85
    King GG, Pare PD, Seow CY. The mechanics of exaggerated airway narrowing in asthma: the role of smooth muscle. Respir Physiol 1999;118: 113.
  • 86
    Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161: 17201745.
  • 87
    Bentley AM, Menz G, Storz C, Robinson DS, Bradley B, Jeffrey PK, et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 1992;146: 500506.
  • 88
    Bentley AM, Jacobson MR, Cumberworth V, Barkans JR, Moqbel R, Schwartz LB, et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992;89: 877883.
  • 89
    Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148: 23902394.
  • 90
    Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10: 471480.
  • 91
    Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 1993;151: 38533865.
  • 92
    Baraniuk JN. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 1997;99: S763S772.
  • 93
    Minshall EM, Cameron L, Lavigne F, Leung DY, Hamilos D, Garcia-Zepada EA, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997;17: 683690.
  • 94
    Vignola AM, Campbell AM, Chanez P, Bousquet J, Paul-Lacoste P, Michel FB, et al. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 1993;148: 689694.
  • 95
    Montefort S, Holgate ST, Howarth PH. Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. Eur Respir J 1993;6: 10441054.
  • 96
    Canonica GW, Ciprandi G, Pesce GP, Buscaglia S, Paolieri F, Bagnasco M. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol 1995;107: 99102.
  • 97
    Chanez P, Vignola AM, Vic P, Guddo F, Bonsignore G, Godard P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999;159: 588595.
  • 98
    Gaga M, Lambrou P, Papageorgiou N, Koulouris NG, Kosmas E, Fragakis S, et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000;30: 663669.
  • 99
    Slavin RG. Asthma and sinusitis. J Allergy Clin Immunol 1992;90: 534537.
  • 100
    Newman LJ, Platts-Mills TA, Phillips CD, Hazen KC, Gross CW. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia (published erratum appears in J Am Med Assoc 1994; 272: 852). J Am Med Assoc 1994;271: 3667.
  • 101
    Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol 2001;107: 7380.
  • 102
    ten Brinke A, Grootendorst DC, Schmidt JT, De Bruine FT, van Buchem MA, Sterk PJ, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 2002;109: 621626.
  • 103
    Vachier I, Chiappara G, Mezziane H, et al. Bronchial and nasal inflammation in asthma and COPD. Am J Respir Crit Care Med 2000;333: A50.
  • 104
    Sutton BJ, Gould HJ. The human IgE network. Nature 1993;366: 421428.
  • 105
    Sherrill DL, Stein R, Halonen M, Holberg CJ, Wright A, Martinez FD, et al. Total serum IgE and its association with asthma symptoms and allergic sensitization among children. J Allergy Clin Immunol 1999;104: 2836.
  • 106
    Beeh KM, Ksoll M, Buhl R. Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals. Eur Respir J 2000;16: 609614.
  • 107
    Arshad SH, Holgate S. The role of IgE in allergen-induced inflammation and the potential for intervention with a humanized monoclonal anti-IgE antibody. Clin Exp Allergy 2001;31: 13441351.
  • 108
    Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 2000;105: 599604.
  • 109
    Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcɛRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997;99: 14921499.
  • 110
    Klein Jan A, Vinke JG, Severijnen LWFM, Fokken WJ. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000;15: 491497.
  • 111
    Ying S, Humbert M, Meng Q, Pfister R, Menz G, Gould HJ, et al. Local expression of ɛ germline gene transcripts and RNA for the ɛ heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J Allergy Clin Immunol 2001;107: 686692.
  • 112
    Rajakulasingam K, Durham SR, O'Brien F, Humbert M, Barata LT, Reece L, et al. Enhanced expression of high-affinity IgE receptor (FcɛRI) α chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells. J Allergy Clin Immunol 1997;100: 7886.
  • 113
    Rajakulasingam K, Till S, Ying S, Humbert M, Barkons J, Sullivan M, et al. Increased expression of high-affinitiy IgE (FcɛRI) receptor-α chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma. Am J Respir Crit Care Med 1998;158: 233240.
  • 114
    Menz G, Ying S, Durham SR, Corrigan CJ, Robinson DS, Hamid O, et al. Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma. Allergy 1998;53: 1521.
  • 115
    Durham SR, Gould HJ, Thienes CP, Jacobson MR, Masuyama K, Rak S, et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997;27: 28992906.
  • 116
    Smurthwaite L, Durham SR. Local IgE synthesis in allergic rhinitis and asthma. Curr Allergy Asthma Rep 2002;2: 231238.
  • 117
    Cameron L, Hamid Q, Wright E, Nakamura Y, Christodoulopoulos P, Mulo S, et al. Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure. J Allergy Clin Immunol 2000;106: 4652.
  • 118
    Smurthwaite L, Walker SN, Wilson DR, Birch DS, Merrett TG, Durham SR, et al. Persistent IgE synthesis in the nasal mucosa of hay fever patients. Eur J Immunol 2001;31: 34223431.
  • 119
    Wilson DR, Merrett TG, Varga EM, Smurthwaite L, Gould HJ, Kemp M, et al. Increases in allergen-specific IgE in BAL after segmental allergen challenge in atopic asthmatics. Am J Respir Crit Care Med 2002;165: 2226.
  • 120
    Denburg JA, Sehmi R, Saito H, Pil-Seob J, Inman MD, O'Byrne PM. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol 2000;106: S242S246.
  • 121
    Inman MD. Bone marrow events in animal models of allergic inflammation and hyperresponsiveness. J Allergy Clin Immunol 2000;106: S235S241.
  • 122
    Gaspar Elsas MI, Joseph D, Elsas PX, Vargaftig BB. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol 1997;17: 404413.
  • 123
    Inman MD, Ellis R, Wattie J, Denburg JA, O'Byrne PM. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol 1999;21: 473479.
  • 124
    Denburg JA, Otsuka H, Ohnisi M, Ruhno J, Bienenstock J, Dolovich J. Contribution of basophil/mast cell and eosinophil growth and differentiation to the allergic tissue inflammatory response. Int Arch Allergy Appl Immunol 1987;82: 321326.
  • 125
    KleinJan A, Dijkstra MD, Boks SS, Severijnen LA, Mulder PG, Fokkens WJ. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation. J Allergy Clin Immunol 1999;103: 441450.
  • 126
    Varga EM, Jacobson MR, Till SJ, Masuyama K, O'Brien F, Rak S, et al. Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis. Allergy 1999;54: 338345.
  • 127
    Lee CH, Lee KS, Rhee CS, Lee SO, Min YG. Distribution of RANTES and interleukin-5 in allergic nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol 1999;108: 594598.
  • 128
    Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99: 837842.
  • 129
    Cameron L, Christodoulopoulos P, Lavigne F, Nakamura Y, Eidelman D, McEuen A, et al. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor. J Immunol 2000;164: 15381545.
  • 130
    Robinson DS, Damia R, Zeibecoglou K, Molet S, North J, Yamada T, et al. CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors. Am J Respir Cell Mol Biol 1999;20: 913.
  • 131
    Kulig M, Bergmann R, Klettke U, Wahn V, Tacke U, Wahn U. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999;103: 11731179.
  • 132
    Kulig M, Klettke U, Wahn V, Forster J, Bauer CP, Wahn U. Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000;106: 832839.
  • 133
    Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis–a prospective follow-up to 7 years of age. Allergy 2000;55: 240245.
  • 134
    Bergmann RL, Edenharter G, Bergmann KE, Forster J, Bauer CP, Wahn V, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998;28: 965970.
  • 135
    Asher MI, Barry D, Clayton T, Crane J, D'Souza W, Ellwood P, et al. The burden of symptoms of asthma, allergic rhinoconjunctivities and atopic eczema in children and adolescents in six New Zealand centres: ISAAC Phase One. N Z Med J 2001;114: 114120.
  • 136
    Peat JK, Salome CM, Woolcock AJ. Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren. J Allergy Clin Immunol 1990;85: 6574.
  • 137
    von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany.Lancet 1998;351: 862866.
  • 138
    Settipane GA, Hagy GW, Settipane RJ. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994;15: 2125.
  • 139
    Plaschke PP, Janson C, Norrman E, Bjornsson E, Ellbjar S, Jarvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med 2000;162: 920924.
  • 140
    Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109: 419425.
  • 141
    Castro-Rodríguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000;162: 14031406.
  • 142
    Panettieri R Jr., Murray RK, Eszterhas AJ, Bilgen G, Martin JG. Repeated allergen inhalations induce DNA synthesis in airway smooth muscle and epithelial cells in vivo. Am J Physiol 1998;274: L417L424.
  • 143
    Chung KF. Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation? Eur Respir J 2000;15: 961968.
  • 144
    Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000;105: 193204.
  • 145
    Bousquet J, Knani J, Dhivert H, Richard A, Chicoye A, Ware JE Jr, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994;149: 371375.
  • 146
    Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94: 182188.
  • 147
    Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000;162: 13911396.
  • 148
    Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, Israel L, et al. The work impact of asthma and rhinitis. Findings from a population-based survey. J Clin Epidemiol 2001;54: 610618.
  • 149
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108: S147S334.
  • 150
    Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91: 97101.
  • 151
    Pedersen B, Dahl R, Lindqvist N, Mygind N. Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma. Allergy 1990;45: 451456.
  • 152
    Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R. Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98: 274282.
  • 153
    Henriksen JM, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984;130: 10141018.
  • 154
    Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146: 122126.
  • 155
    Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992;90: 250256.
  • 156
    Greiff L, Andersson M, Svensson C, Linden M, Wollmer P, Brattsand R, et al. Effects of orally inhaled budesonide in seasonal allergic rhinitis. Eur Respir J 1998;11: 12681273.
  • 157
    Grant JA, Nicodemus CF, Findlay SR, Glovsky MM, Grossman J, Kaiser H, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol1995; 95: 923932.
  • 158
    Van-Ganse E, Kaufman L, Derde MP, Yernault JC, Delaunois L, Vincken W. Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur Respir J 1997;10: 22162224.
  • 159
    Meltzer E, Malmstrom K, Lu S, Brenner B, Wei L, Weinstein S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: placebo-controlled clinical trial. J Allergy Clin Immunol 2000;105: 917922.
  • 160
    Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102: 558562.
  • 161
    Norman PS. Is there a role for immunotherapy in the treatment of asthma? (Yes editorial). Am J Respir Crit Care Med 1996;154: 12251226.
  • 162
    Barnes P. Is there a role for immunotherapy in the treatment of asthma? No. Am J Respir Crit Care Med 1996;154: 12271228.
  • 163
    Bousquet J, Demoly P, Michel FB. Specific immunotherapy in rhinitis and asthma. Ann Allergy Asthma Immunol 2001;87 (1 Suppl. 1):3842.
  • 164
    Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102: 157164.
  • 165
    Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109: 251256.
  • 166
    Ädelroth E, Rak S, Haahtela T, Aasand G, Rosenhall L, Zetterstrom O, et al. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000;106: 253259.
  • 167
    Chervinsky P, Busse W, Casale T, Nayak A, Tripathy I, Fowler Taylor A, et al. Xolair® in the treatment of perennial allergic rhinitis (Abstract 513). J Allergy Clin Immunol 2001;107.
  • 168
    Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, et al. Treatment of childhood asthma with anti-IgE antibody omalizumab. Pediatrics 2001;108 URL: http://www.pediatrics.org/cgi/content/full/108/2/e36.
  • 169
    Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108: 184190.
  • 170
    Solèr M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001;18: 254261.
  • 171
    Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002;109: 5762.
  • 172
    Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002;109: 636642.